Company overview
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing GEHC with another company.
| Daily close (USD) | $64.22 |
| Market capitalization (USD) | $29,213,150,496.92 |
| Price / earnings (TTM) | 14.72 |
| Price / book | 2.6 |
No matching rows. Clear the filter to see all records.
Read GEHC's valuation metrics
Company size
GE HealthCare Technologies Inc. Common Stock's recorded market capitalization is $29,213,150,496.92. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
GEHC's recorded P/E is 14.72: about $14.72 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
GEHC's recorded price-to-book ratio is 2.6. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research GE HealthCare Technologies Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about GEHC. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow GEHC's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.